These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19538865)
1. [Functional significance of TGF-beta1 signal transduction pathway in oral squamous cell carcinoma]. Wang XM; Liu CM; Zhang CR; Xu XG; Fu SB Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):28-32. PubMed ID: 19538865 [TBL] [Abstract][Full Text] [Related]
2. TGF-β1/TβRII/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages. Sun H; Miao C; Liu W; Qiao X; Yang W; Li L; Li C Biochem Biophys Res Commun; 2018 Mar; 497(2):583-590. PubMed ID: 29462614 [TBL] [Abstract][Full Text] [Related]
3. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas. Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma. Wang X; Sun W; Bai J; Ma L; Yu Y; Geng J; Qi J; Shi Z; Fu S Mol Biol Rep; 2009 May; 36(5):861-9. PubMed ID: 18418730 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of TGF-beta1 and its signaling pathway proteins in nasopharyngeal carcinoma]. Sun R; Chen MY; Sun J; Zhang Y; Zhang CQ; Hou JH; Hong MH Ai Zheng; 2007 Sep; 26(9):1005-9. PubMed ID: 17927862 [TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120 [TBL] [Abstract][Full Text] [Related]
7. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma. Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018 [TBL] [Abstract][Full Text] [Related]
8. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4. Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts. Meng W; Xia Q; Wu L; Chen S; He X; Zhang L; Gao Q; Zhou H BMC Cancer; 2011 Feb; 11():88. PubMed ID: 21352603 [TBL] [Abstract][Full Text] [Related]
10. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression in multiple components of the transforming growth factor-β1-induced Smad signaling pathway during 7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch squamous-cell carcinogenesis. Chen YK; Yang SH; Huang AH; Hsue SS; Lin LM Oral Oncol; 2011 Apr; 47(4):262-7. PubMed ID: 21356605 [TBL] [Abstract][Full Text] [Related]
12. [Expressions and clinical significance of TGF-βRII and NF-κB in oral squamous cell carcinoma]. Jiang LL; Zhao YJ; Li Y Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):729-733. PubMed ID: 28275800 [TBL] [Abstract][Full Text] [Related]
13. [Expression of transforming growth factor beta(TGF-beta) subtypes in oral squamous cell carcinoma]. Jin X; Li J; Li Z; Li Y Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):377-9. PubMed ID: 12539688 [TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma. Iamaroon A; Pattamapun K; Piboonniyom SO J Oral Sci; 2006 Sep; 48(3):105-9. PubMed ID: 17023741 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features. Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582 [TBL] [Abstract][Full Text] [Related]
16. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma. Dong Z; Guo W; Guo Y; Kuang G; Yang Z Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Study of TGF-β1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma: Correlations Between Clinicopathologic Factors and Overall Survival. Wagner VP; Cardoso PR; Dos Santos JN; Meurer L; Vargas PA; Fonseca FP; Carrard VC; Martins MD Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):651-659. PubMed ID: 26990749 [TBL] [Abstract][Full Text] [Related]
18. [Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer]. Lu B; Zhou YN; Li Q; Wu ZQ; Zhang ZY; Ji R; Guo QH; Liu W Ai Zheng; 2009 May; 28(5):538-42. PubMed ID: 19624886 [TBL] [Abstract][Full Text] [Related]
19. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer. Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of integrin β6 transcription induced by TGF-β1 in human oral squamous cell carcinoma cells. Xu M; Yin L; Cai Y; Hu Q; Huang J; Ji Q; Hu Y; Huang W; Liu F; Shi S; Deng X J Cell Biochem; 2018 May; 119(5):4193-4204. PubMed ID: 29274289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]